 
 
Disclaimer: The below article is sponsored, and the views in it do not represent those of ZyCrypto. Readers should conduct independent research before taking any actions related to the project mentioned in this piece. This article should not be regarded as investment advice.
GSR, a leading capital markets partner in the crypto industry, has announced a landmark $100 million private placement into MEI Pharma, Inc. (NASDAQ: MEIP), marking a bold step toward positioning Litecoin (LTC) as an institutional-grade treasury asset. As part of the strategic deal, GSR will assume the role of both strategic advisor and digital asset treasury manager for MEI Pharma.
In a move designed to bring Litecoin into mainstream corporate finance, GSR will collaborate closely with Charlie Lee, the creator of Litecoin, who will also take a seat on MEI’s Board of Directors. A GSR representative will also join the board, strengthening the company’s pivot toward crypto-driven initiatives. The partnership aligns with MEI’s recently declared shift in strategic direction, underscoring its ambition to integrate digital asset strategies with public market operations.
Charlie Lee, creator of Litecoin, remarked:
“Litecoin has consistently delivered a stable, low-cost, and accessible network for over a decade. With leading global transaction volume on platforms like BitPay, Litecoin is trusted by users and integrated across retail and payments. This partnership with GSR and MEI brings that utility and mission into an institutional setting for the first time.”
 
MEI Pharma’s leadership views the partnership as a critical bridge between traditional markets and digital innovation. By partnering with GSR for its treasury strategy, MEI is positioning itself among the first publicly listed firms to adopt and manage Litecoin (LTC) as part of a structured institutional approach.
Joshua Riezman, U.S. Chief Strategy Officer at GSR, described the partnership as a pivotal moment for Litecoin, elevating it as a serious and credible asset class. He emphasized that trust in Litecoin’s regulatory clarity, durability, and long-term potential is at an unprecedented high.
Quynh Ho, GSR’s Head of Venture Investment, reinforced this view, noting that while institutional interest in Litecoin is steadily growing, there are few secure and well-structured options for entry. Ho explained that this investment aims to fill that gap, offering a strong framework for access while highlighting Litecoin’s proven resilience and staying power.
The $100 million PIPE round was co-led by Charlie Lee, GSR, and the Litecoin Foundation, with backing from notable crypto venture firms and infrastructure partners, including Mozayyx, Parafi, HiveMind, Primitive, RLH Capital, Delta Blockchain, and CoinFund.
Beyond this initiative, GSR remains a prominent player in the broader digital asset ecosystem, providing liquidity, capital, and advisory services. The firm’s experience includes backing innovative protocols such as Katana, a Polygon-based DeFi project, underscoring its reputation as a catalyst for emerging blockchain ecosystems.
About GSR
GSR stands as a leading capital markets partner in the cryptocurrency sector, offering expertise in market-making, institutional over-the-counter (OTC) trading, and strategic venture capital investments. With over a decade of knowledge, GSR supports founders, institutions, and digital ecosystems by delivering market intelligence, liquidity solutions, and strategic guidance.
For more information, visit www.gsr.io.
Source: https://zycrypto.com/gsr-invests-100m-in-mei-pharma-to-launch-first-institutional-litecoin-treasury-with-charlie-lee/